why choose us

First received: October 21, 2026

Clinical Trial: Pulsed Field Ablation of Atrial Fibrillation: CENTAURI Versus FARAPULSE

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Atrial Fibrillation; Paroxysmal Atrial Fibrillation; Persistent Atrial Fibrillation

Study Type: INTERVENTIONAL


Official Title: Prospective Randomized Clinical Comparison of Catheter Ablation of Atrial Fibrillation Using the CENTAURI PEF System and the FARAPULSE System

Brief Summary: The aim of this study is to compare the efficacy of two commercially available pulsed field ablation (PFA) systems for catheter ablation of atrial fibrillation. Patients are randomized 1:1 to point-by-point PFA using the CENTAURI PEF system with 3D electroanatomical mapping, or to single-shot PFA using the FARAPULSE pentaspline catheter guided by fluoroscopy and intracardiac echocardiography. The primary endpoint is freedom from documented atrial arrhythmia recurrence between 3 and 12 months after ablation.

Read more